Provexis (PXS) Competitors GBX 0.58 -0.07 (-10.00%) As of 11:25 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitors PXS vs. NSH, ALK, SHIP, TORO, CLCO, ICON, PAA, GEL, MMP, and AALShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), Tufton Oceanic Assets (SHIP), Chenavari Toro Income Fund (TORO), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), and Anglo American (AAL). These companies are all part of the "transportation" industry. Provexis vs. Norish Alkemy Capital Investments Tufton Oceanic Assets Chenavari Toro Income Fund CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Anglo American Norish (LON:NSH) and Provexis (LON:PXS) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends. Do insiders & institutionals have more ownership in NSH or PXS? 7.9% of Provexis shares are owned by institutional investors. 21.6% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer NSH or PXS? Provexis received 16 more outperform votes than Norish when rated by MarketBeat users. However, 68.18% of users gave Norish an outperform vote while only 64.21% of users gave Provexis an outperform vote. CompanyUnderperformOutperformNorishOutperform Votes4568.18% Underperform Votes2131.82% ProvexisOutperform Votes6164.21% Underperform Votes3435.79% Does the media prefer NSH or PXS? In the previous week, Norish's average media sentiment score of 0.00 equaled Provexis'average media sentiment score. Company Overall Sentiment Norish Neutral Provexis Neutral Is NSH or PXS more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets NorishN/A N/A N/A Provexis -73.10%-138.67%-56.14% Which has preferable earnings and valuation, NSH or PXS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorish£36.39M0.00N/A£6.10N/AProvexis£426.17K31.02N/AN/AN/A SummaryNorish beats Provexis on 5 of the 9 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£13.22M£1.16B£5.39B£2.04BDividend Yield5.06%3.04%5.37%5.16%P/E Ratio43.75129.7488.271,926.65Price / Sales31.022,916.711,286.07384,006.48Price / CashN/A10.2536.6029.21Price / BookN/A3.234.953.08Net IncomeN/A£152.21M£117.96M£183.60M7 Day Performance-5.19%-0.10%2.54%3.09%1 Month Performance-10.00%3.14%3.49%3.42%1 Year Performance-19.31%103.04%27.05%165.41% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.59-10.0%N/A-20.0%£13.22M£426,168.0043.754Positive NewsGap UpNSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 162-6.1%N/A+56.1%£14.27MN/A-704.3525,500High Trading VolumeSHIPTufton Oceanic AssetsN/AGBX 1.19-0.8%N/A+11.1%£3.47M£39.75M9.9250News CoverageTOROChenavari Toro Income FundN/AGBX 0.58-0.7%N/A+27.0%£1.78MN/A-19.37N/ACLCOCloudCoCo GroupN/AGBX 0.16+1.9%N/A-78.8%£1.12M£27.31M-115.00125Gap DownICONIconic LabsN/AN/AN/AN/A£586,000.00£600,855.00-15.003Gap UpHigh Trading VolumePAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660AALAnglo American0.8409 of 5 starsGBX 2,448-1.0%GBX 2,715+10.9%+47.8%£29.62B£29.44B-2,353.85129,700Gap Down Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives Tufton Oceanic Assets Alternatives Chenavari Toro Income Fund Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Anglo American Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PXS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.